Functional CRISPR dissection of gene networks controlling human regulatory T cell identity

[1]  Y. Okada,et al.  Regulatory T Cell-Specific Epigenomic Region Variants Are a Key Determinant of Susceptibility to Common Autoimmune Diseases. , 2020, Immunity.

[2]  J. Bluestone,et al.  Next-generation regulatory T cell therapy , 2019, Nature Reviews Drug Discovery.

[3]  A. Rao,et al.  Loss of TET2 and TET3 in regulatory T cells unleashes effector function , 2019, Nature Communications.

[4]  Atique U. Ahmed,et al.  HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma , 2019, Cell reports.

[5]  C. Leslie,et al.  Transcription factor Foxp1 regulates Foxp3 chromatin binding and coordinates regulatory T cell function , 2019, Nature Immunology.

[6]  John Lamb,et al.  Guide Swap enables genome-scale pooled CRISPR–Cas9 screening in human primary cells , 2018, Nature Methods.

[7]  A. Ashworth,et al.  Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function , 2018, Cell.

[8]  P. Sharma,et al.  Modulation of EZH2 expression in T cells improves efficacy of anti–CTLA-4 therapy , 2018, The Journal of clinical investigation.

[9]  J. Bluestone,et al.  Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity , 2018, Cell reports.

[10]  Chun Jimmie Ye,et al.  Multiplexed droplet single-cell RNA-sequencing using natural genetic variation , 2017, Nature Biotechnology.

[11]  M. Sarwal,et al.  Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  U. Klein,et al.  NF-κB c-Rel Is Crucial for the Regulatory T Cell Immune Checkpoint in Cancer , 2017, Cell.

[13]  B. Rouse,et al.  The Plasticity and Stability of Regulatory T Cells during Viral-Induced Inflammatory Lesions , 2017, The Journal of Immunology.

[14]  J. Kirkwood,et al.  Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity , 2017, Cell.

[15]  A. Rudensky,et al.  Stability and function of regulatory T cells expressing the transcription factor T-bet , 2017, Nature.

[16]  G. Nolan,et al.  Automated Mapping of Phenotype Space with Single-Cell Data , 2016, Nature Methods.

[17]  W. Chung,et al.  Mutations in HIVEP2 are associated with developmental delay, intellectual disability, and dysmorphic features , 2016, neurogenetics.

[18]  Harri Lähdesmäki,et al.  Control of Foxp3 stability through modulation of TET activity , 2016, The Journal of experimental medicine.

[19]  Jeffrey A. Bluestone,et al.  Type 1 diabetes immunotherapy using polyclonal regulatory T cells , 2015, Science Translational Medicine.

[20]  T. Holderried,et al.  Stable inhibitory activity of regulatory T cells requires the transcription factor Helios , 2015, Science.

[21]  Sean C. Bendall,et al.  An interactive reference framework for modeling a dynamic immune system , 2015, Science.

[22]  T. Wieland,et al.  Loss-of-function variants in HIVEP2 are a cause of intellectual disability , 2015, European Journal of Human Genetics.

[23]  T. Chatila,et al.  Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy. , 2015, Immunity.

[24]  B. van Steensel,et al.  Easy quantitative assessment of genome editing by sequence trace decomposition , 2014, Nucleic acids research.

[25]  M. Daly,et al.  Genetic and Epigenetic Fine-Mapping of Causal Autoimmune Disease Variants , 2014, Nature.

[26]  Aaron N. Chang,et al.  Id2 and Id3 maintain the regulatory T cell pool to suppress inflammatory disease , 2014, Nature Immunology.

[27]  T. Hannon.  “Do you catch my drift?” , 2014, Transfusion.

[28]  J. Kawai,et al.  The enhancer and promoter landscape of human regulatory and conventional T-cell subpopulations. , 2014, Blood.

[29]  Hiroshi Takayanagi,et al.  Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis , 2013, Nature Medicine.

[30]  P. Delvenne,et al.  Infusion of clinical‐grade enriched regulatory T cells delays experimental xenogeneic graft‐versus‐host disease , 2013, Transfusion.

[31]  E. Clambey,et al.  Hypoxia-inducible factor-1 alpha–dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa , 2012, Proceedings of the National Academy of Sciences.

[32]  James J. Collins,et al.  A multiple redundant genetic switch locks in the transcriptional signature of T regulatory cells , 2012, Nature Immunology.

[33]  Scott A. Shaffer,et al.  Transcription factor Foxp3 and its protein partners form a complex regulatory network , 2012, Nature Immunology.

[34]  A. Rudensky,et al.  An N-terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbates diabetes. , 2012, Immunity.

[35]  T. Tahira,et al.  Genome-wide Repression of NF-κB Target Genes by Transcription Factor MIBP1 and Its Modulation by O-Linked β-N-Acetylglucosamine (O-GlcNAc) Transferase* , 2012, The Journal of Biological Chemistry.

[36]  P. Krammer,et al.  Molecular Mechanisms of Treg-Mediated T Cell Suppression , 2012, Front. Immun..

[37]  H. Kanegane,et al.  Identification of FOXP3-negative regulatory T-like (CD4(+)CD25(+)CD127(low)) cells in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. , 2011, Clinical immunology.

[38]  J. Buckner,et al.  CD4+FOXP3+ T Regulatory Cells in Human Autoimmunity: More Than a Numbers Game , 2011, The Journal of Immunology.

[39]  R. Balderas,et al.  Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation , 2011, Nature Immunology.

[40]  C. Baecher-Allan,et al.  Identification of T helper type 1–like, Foxp3+ regulatory T cells in human autoimmune disease , 2011, Nature Medicine.

[41]  W. Shi,et al.  The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells , 2011, Nature Immunology.

[42]  L. Glimcher,et al.  Dampening of death pathways by Schnurri 2 is essential for T cell development , 2011, Nature.

[43]  Daniel R. Beisner,et al.  Foxo transcription factors control regulatory T cell development and function. , 2010, Immunity.

[44]  Y. Belkaid,et al.  Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory Cells , 2010, The Journal of Immunology.

[45]  C. Akdis,et al.  Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells , 2009, The Journal of experimental medicine.

[46]  A. Rudensky,et al.  Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responses , 2009, Nature.

[47]  G. Szot,et al.  Expansion of Human Regulatory T-Cells From Patients With Type 1 Diabetes , 2009, Diabetes.

[48]  K. Kretschmer,et al.  DNA methylation controls Foxp3 gene expression , 2008, European journal of immunology.

[49]  D. Levy,et al.  IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways , 2007, Nature Immunology.

[50]  S. Ishii,et al.  Schnurri-2 Controls Memory Th1 and Th2 Cell Numbers In Vivo1 , 2007, The Journal of Immunology.

[51]  Vincent C. Manganiello,et al.  Foxp3-dependent programme of regulatory T-cell differentiation , 2007, Nature.

[52]  Y. Wan,et al.  Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression , 2007, Nature.

[53]  RiceDerik.  More Than a Numbers Game , 2003 .

[54]  S. Ishii,et al.  Murine Schnurri-2 is required for positive selection of thymocytes , 2001, Nature Immunology.

[55]  H. Ochs,et al.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.